Russell Investments Group, Ltd. Vbi Vaccines Inc Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.73 - $23.4 $3,223 - $103,334	-4,416 Reduced 21.45%	16,176 $11,000
Q1 2022 May 05, 2022	BUY	$1.27 - $2.47 $26,151 - $50,862	20,592 New	20,592 $34,000
Q2 2018 Aug 08, 2018	SELL	$2.75 - $3.85 $1.35 Million - $1.89 Million	-491,449 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$3.5 - $4.47 $117,558 - $150,138	33,588 Added 7.34%	491,449 $1.72 Million
Q4 2017 Feb 06, 2018	BUY	$3.29 - $5.03 $370,908 - $567,072	112,738 Added 32.67%	457,861 $1.96 Million
Q3 2017 Nov 07, 2017	BUY	$3.15 - $4.01 $1.09 Million - $1.38 Million	345,123	345,123 $1.33 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.